News
NRXP
3.320
+0.91%
0.030
NRX Pharmaceuticals (NRXP) Receives a Rating Update from a Top Analyst
TipRanks · 1d ago
Weekly Report: what happened at NRXP last week (0914-0918)?
Weekly Report · 2d ago
NRX Pharmaceuticals Gains FDA Boost for Ketamine Review
TipRanks · 09/16 10:45
NRx Pharmaceuticals Reports FDA Reclassifies Ketamine Amendment As Minor
NASDAQ · 09/16 05:32
NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’
TipRanks · 09/15 19:15
FDA Reclassifies NRx Pharmaceuticals' Ketamine ANDA Amendment To Minor, Setting New Goal Date For November 10, 2026
Benzinga · 09/15 19:12
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Barchart · 09/15 14:11
Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Hyperfine (HYPR)
TipRanks · 09/15 10:30
NRX Pharmaceuticals Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 09/14 18:51
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target
Benzinga · 09/14 18:40
NRx Pharmaceuticals: Promising Ketamine Opportunity In Psychiatry
Seeking Alpha · 09/14 14:26
GeNeuro Secures European Patent For GNK-301 In ALS
NASDAQ · 09/14 13:23
NRx Pharmaceuticals Enhances Investor Outreach with Updated Presentation
TipRanks · 09/14 12:33
NRx Pharma’s GeNeuro Announces Award Of European Patent Entitled Anti HERV K Envelope Antibody And Uses Thereof
Benzinga · 09/14 11:05
Weekly Report: what happened at NRXP last week (0907-0911)?
Weekly Report · 09/14 09:55
NRx Pharmaceuticals’ HOPE Therapeutics To Deploy Zeta Surgical's Newly FDA-Cleared Zeta TMS Robotic System, With Clinical Staff Now In Training Ahead Of Deployment In Florida
Benzinga · 09/11 11:04
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Barchart · 09/11 06:00
Weekly Report: what happened at NRXP last week (0831-0904)?
Weekly Report · 09/07 09:50
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), NRX Pharmaceuticals (NRXP) and Innate Pharma (IPHA)
TipRanks · 09/02 10:30
Weekly Report: what happened at NRXP last week (0824-0828)?
Weekly Report · 08/31 09:55
More
Webull provides a variety of real-time NRXP stock news. You can receive the latest news about Nrx Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.